November 2020 - Page 2 of 6 - BioMedWire (BMW)

FridayNov 20, 2020 1:00 pm

Researchers May Have Found a New Way to Predict Cancer Susceptibility

A new study by researchers from the University of Birmingham suggests that environmental cancer-causing agents may be used to help understand effects of exposure in addition to helping predict the individuals who may be more susceptible to developing cancer. Every individual has been exposed to low levels of radiation or substances that promote cancer development, commonly known as carcinogens. Benzopyrene, which is a widely used chemical pollutant, is found in barbequed fish and meat, exhaust fumes and wood-burning stoves. The pollutant has BPDE, which is an active ingredient that forms DNA adducts. These are damaged DNA that promote mutations that…

FridayNov 20, 2020 11:00 am

Research Finds That Masks Don’t Affect Lung Function When Exercising

A new study published in the “Annals of the American Thoracic Society” indicates that wearing a face mask does not diminish lung function. The team of Canadian and American researchers that worked on the study discovered that while individuals may experience an increase in shortness of breath when wearing a face mask, there was no factual evidence showing that masks decreased lung function. This applies even when masks are worn during heavy exercise. Face mask prevalence has grown since the onset of the coronavirus pandemic and has been touted as a way to effectively reduce the spread of the virus.…

ThursdayNov 19, 2020 2:13 pm

CNS Pharmaceuticals (NASDAQ: CNSP) Outlines Plans for Advancing Drug It Hopes Will Beat Deadly Brain Cancer

Biotechnology developer CNS Pharmaceuticals is working to advance the clinical trials of a novel brain cancer-fighting drug candidate with the aim of developing a new, effective therapy for treating an otherwise incurable disease The company plans a complex, multi-armed Phase 2 trial of its candidate Berubicin in hopes that the drug candidate may ultimately gain an expedited pathway to approval and registration from the FDA The trial for combatting Glioblastoma Multiforme is expected to begin next year, and on Nov. 12 the company’s officers launched a webinar to provide information on how the trial will be designed CNS Pharmaceuticals is…

ThursdayNov 19, 2020 1:00 pm

Research Shows That Healthy Sleep Patterns Decrease Heart Failure Risk

According to new research that was reported in “Circulation,” the American Heart Association journal, adults who had healthy sleeping patterns had a lower risk of heart failure. This was in comparison to grown-ups who had unhealthy sleep patterns. Healthy sleeping patterns are characterized by waking up in the morning, sleeping seven to eight hours every day and having no excessive daytime sleepiness, snoring or frequent insomnia. Emerging evidence shows that sleep problems may have a hand in heart failure development. Heart failure affects over 26 million individuals globally. The observational study looked into the relationship between heart failure and healthy…

ThursdayNov 19, 2020 11:00 am

Eating Early Has No Impact on Weight-Loss Efforts

According to ongoing research that was presented during a recent virtual meeting at the American Heart Association Scientific Session, it was discovered that limiting meals to early in the day didn’t affect the weight of overweight adults who have diabetes or prediabetes. Associate professor of epidemiology, nursing and medicine at Johns Hopkins, Nisa M. Maruthur, the study’s author, stated that researchers had questioned the possibility of whether the time that an individual ate during the day affected how their body stored and used energy. Prior studies had not controlled the number of calories people consumed. It had therefore not been…

WednesdayNov 18, 2020 1:00 pm

New Genetic Analysis Technique Can Predict Possibility of Cancer Treatment Side Effects

Using a model developed at the Linköping University in Sweden, scientists can now predict the risk of any adverse effects on the bone marrow and blood status of cancer patients undergoing chemotherapy. This study may make it possible to utilize genetic analysis in identifying patients who have a high probability of side effects. The research was reported in “npj Systems Biology and Applications.” Health practitioners find it difficult to strike a balance between not causing severe side effects during cancer treatment while simultaneously trying to eliminate as many tumor cells as possible. Tumor cells are known to grow in an…

WednesdayNov 18, 2020 11:00 am

Eating Too Many Eggs Increases Risk of Developing Diabetes

Globally, some of the most popular breakfast food includes eggs, be it boiled, poached or scrambled. However, new research shows that excessive consumption of eggs may increase your risk of diabetes. The longitudinal study, which was conducted by researchers from the University of South Australia in collaboration with Qatar University and China Medical University, was carried out between 1991 and 2009. This was the first study to evaluate the consumption of eggs in a large number of Chinese adults. The study discovered that individuals who consumed one or more eggs on a regular basis, which is equivalent to 50 grams,…

TuesdayNov 17, 2020 3:12 pm

Brain Scientific Inc. (BRSF) Offers Stock to Wider Pool of Investors Through Dalmore Group

BRSF announce partnership with Dalmore Group New product launch presents solution for growing need for rapid EEG testing due to COVID-19 pandemic Brain Scientific shose to extend proposed Reg A+ offering to attract additional investors Brain Scientific (BRSF), a commercial-stage healthcare company providing next-gen solutions to the neurology market, has announced a partnership with the Dalmore Group in a recent press release (https://ibn.fm/clcDx). "We are delighted to get the Dalmore Group on board and to be able to offer our stock to a much wider pool of investors,” said Brain Scientific chairman Boris Goldstein. “Our partners are experienced with Regulation…

TuesdayNov 17, 2020 2:56 pm

AzurRx BioPharma Inc. (NASDAQ: AZRX) Making Strides with MS1819 Clinical Trials for Cystic Fibrosis-Associated Pancreatic Insufficiency

Globally it is estimated that 70,000 people suffer from CF, with half the population in the United States The global CF therapeutics market size was valued at $4.62 billion in 2018 and is expected to reach an estimated $9.3 billion by 2026 AzurRx BioPharma’s MS1819, currently undergoing clinical trials, is a promising therapy for severe exocrine pancreatic insufficiency in patients with cystic fibrosis While still a relatively rare genetic disease, cystic fibrosis (“CF”) remains a dangerous condition that affects multiple body functions and organs, putting patients at risk of developing severe life-threatening illnesses. This is why the need for innovative…

TuesdayNov 17, 2020 1:00 pm

California Researchers Develop Face Mask That Can Kill Viruses Once Exposed to the Sun

A team of Californian researchers has developed a cotton fabric that can release oxygen species that are reactive (ROS). The fabric does this when exposed to daylight, which kills microbes that are attached to the cotton fabric’s surface. The fabric is also washable, making it reusable and safe for its wearer. This research was reported in “The American Chemical Society Applied Materials & Interfaces” journal. This news comes at a time when face masks being used are made from different cloth materials that filter tiny aerosol particles like those that are released by a sneeze or a cough. This leaves…